Sigyn Therapeutics (SIGY) Asset Utilization Ratio (2018 - 2020)
Sigyn Therapeutics (SIGY) posted Asset Utilization Ratio of 0.02 for Q3 2020, down 73.51% sequentially from 0.06 in Q2 2020, and down 90.88% YoY from 0.18 in Q4 2019.
Sigyn Therapeutics (SIGY) Asset Utilization Ratio (2018 - 2020) Analysis & Trends
Sigyn Therapeutics has reported Asset Utilization Ratio for 3 years, with the latest figure at 0.02 in Q3 2020.
- Quarterly Asset Utilization Ratio fell 90.88% year-over-year to 0.02 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was 0.02 (down 90.88% YoY) and the FY2018 annual result came in at 0.02, changed N/A from the prior year.
- Asset Utilization Ratio retreated to 0.02 in Q3 2020 per SIGY's latest filing, from 0.06 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.24 in Q2 2019 and troughed at 0.42 in Q3 2018.
- A 3-year average of 0.01 and a median of 0.06 in 2020 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2019 and 2020: Asset Utilization Ratio soared 257.36% in 2019, then slumped 90.88% in 2020.
- Over 3 years, Asset Utilization Ratio stood at 0.09 in 2018, then surged by 105.39% to 0.18 in 2019, then plunged by 90.88% to 0.02 in 2020.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.02, 0.06, and 0.18 for Q3 2020, Q2 2020, and Q3 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 0.02 |
| Jun 30, 2020 | 0.06 |
| Sep 30, 2019 | 0.18 |
| Jun 30, 2019 | 0.24 |
| Mar 31, 2019 | 0.16 |
| Dec 31, 2018 | 0.09 |
| Sep 30, 2018 | -0.42 |
| Jun 30, 2018 | -0.32 |
| Mar 31, 2018 | -0.10 |